Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality.

Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality. J Thorac Dis. 2018 Jun;10(Suppl 17):S2004-S2006 Authors: Niska JR, Sio TT, Daniels TB, Beamer SE, Jaroszewski DE, Ross HJ, Paripati HR, Schild SE PMID: 30023104 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30023104?dopt=Abstract

Source: Journal of Thoracic Disease - July 21, 2018 Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer